Until now, most of the evidence linking insulin and glucose to atherosclerosis comes from studies in which atherosclerotic cardiovascular clinical endpoints, such as ischemic heart disease or ischemic stroke, were investigated (19, 20, 21). The gene discussed is INS; the disease is coronary artery disorder.